The use of Nibima and Immunim, two Ghanaian herbal medicines in the management of mild COVID ‐19: A case report

Key Clinical MessageNibima andImmunim manages mild COVID-19 in 7  days.AbstractCoronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can lead to severe complications and deaths. The search for phytotherapeutic agents to augment the fight against the current COVID-19 pandemic is therefore of highest priority. A 52-year-old female with no history of chronic illness presented to our clinic facility with a 3  days loss of smell and headache which persisted after self-medication. The patient tested positive for COVID-19 in the SARS-CoV-2 Ag test as well as the Typhoid rapid antibody test. Routine laboratory tests were not remarkable. A 60 mL three times daily dose ofNibima and 5  mL in 40 mL of warm water dose ofImmunim were given to the patient for 7  days. Patient recovered sense of smell and regained appetite but cough although reduced persisted. She also tested negative for COVID-19 after 7 days treatment. This case is the first documented case of COVID-19 management with herbal medicines in Ghana. We strongly suggest a larger control tri al on these products to ascertain these findings to repurpose them as viable treatments for COVID-19.
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: CASE REPORT Source Type: research